Long-haul COVID-19 shares symptoms with ME/CFS (Sukocheva et al., 2022), and studies have found increased β2-adrenergic receptors and muscarinic M3R and M4R AABs in patients with CFS. Here, CHRM4 is linked to COVID-19.